Travere Therapeutics (TVTX) Change in Taxes (2015 - 2017)

Travere Therapeutics (TVTX) posted Change in Taxes of -$181000.0 for Q1 2017, up 97.88% on a QoQ basis from -$8.5 million in Q4 2016.

Travere Therapeutics (TVTX) Change in Taxes (2015 - 2017) Analysis & Trends

Travere Therapeutics' Change in Taxes history runs 3 years deep, the most recent figure standing at -$181000.0 for Q1 2017.

Quarterly Change in Taxes changed N/A year-over-year to -$181000.0 in Q1 2017, while the trailing twelve-month figure through Mar 2017 was -$10.2 million (changed N/A YoY) and the FY2019 annual result came in at -$555000.0, up 50.71% from the prior year.
Change in Taxes was -$181000.0 for Q1 2017 at Travere Therapeutics, up from -$8.5 million in the prior quarter.
Across five years, Change in Taxes topped out at -$181000.0 in Q1 2017 and bottomed at -$8.5 million in Q4 2016.
A 3-year average of -$3.4 million and a median of -$1.5 million in 2015 frame the typical range for Change in Taxes.
Peak annual rise in Change in Taxes reached 460.36% in 2016, while the deepest fall reached 460.36% in 2016.
Travere Therapeutics' Change in Taxes stood at -$1.5 million in 2015, then sank by 460.36% to -$8.5 million in 2016, then jumped by 97.88% to -$181000.0 in 2017.
Business Quant data shows TVTX's Change in Taxes at -$181000.0 in Q1 2017, -$8.5 million in Q4 2016, and -$1.5 million in Q4 2015.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Taxes (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-8,939.03
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	-
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	-
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Travere Therapeutics	5.21 Bn	5.21 Bn	125.25 Mn	-

Download Data